---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-26-001169"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2026-08-21T21:25:19+00:00"
generated_at: "2026-08-21T21:26:04.915546+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Starling Oncology signs $25M revolver with SLR Healthcare ABL; $4.75M drawn at close

## Summary
- Credit agreement dated Aug 20, 2026; facility up to $25M, secured by substantially all SOM, LLC collateral.
- $4.75M outstanding as of Aug 21, 2026 closing date; proceeds for working capital and general corporate purposes.
- Maturity Aug 20, 2029; interest at Term SOFR (floor 2.00%) plus 3.95%, default rate adds 5.00%.
- Borrowing base formula on receivables; covenants cap Maximum Loan Turn Days at 35 on rolling 3-month basis.
- Fees include collateral monitoring 0.0833%/mo, unused line 0.04166%/mo, and termination fees up to 3%.

## SEC filing metadata
- accession: 0001079973-26-001169
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2026-08-21T21:25:19+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997326001169/0001079973-26-001169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997326001169/stln_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-26-001169
- JSON: https://secwatch.observer/filing/0001079973-26-001169.json
- Plain text: https://secwatch.observer/filing/0001079973-26-001169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.